UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of azithromycin on sputum inflammatory markers in bronchiectasis

BMC pulmonary medicine, 2023-04, Vol.23 (1), p.151-151, Article 151

2023

Volltextzugriff (PDF)

Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype

Journal of cystic fibrosis, 2022-03, Vol.21 (2), p.254-257

2022

Volltextzugriff (PDF)

Sinonasal manifestations of cystic fibrosis: A correlation between genotype and phenotype?

Journal of cystic fibrosis, 2014-07, Vol.13 (4), p.442-448

2014

Volltextzugriff (PDF)

Effectiveness of pulmonary rehabilitation at high-altitude compared to sea-level in adults with severe refractory asthma

Respiratory medicine, 2020-09, Vol.171, p.106123-106123, Article 106123

2020

Volltextzugriff (PDF)

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus

The European respiratory journal, 2000-10, Vol.16 (4), p.749-767

2000

Volltextzugriff (PDF)

Non-fasting bioelectrical impedance analysis in cystic fibrosis: Implications for clinical practice and research

Journal of cystic fibrosis, 2020-01, Vol.19 (1), p.153-158

2020

Volltextzugriff (PDF)

Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥ 90% predicted at baseline

Journal of cystic fibrosis, 2020-07, Vol.19 (4), p.654-658

2020

Volltextzugriff (PDF)

Resting energy expenditure in cystic fibrosis patients decreases after lung transplantation, which improves applicability of prediction equations for energy requirement

Journal of cystic fibrosis, 2020-11, Vol.19 (6), p.975-980

2020

Volltextzugriff (PDF)

The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol

Contemporary clinical trials communications, 2022-12, Vol.30, p.101045-101045, Article 101045

2022

Volltextzugriff (PDF)

CT-abnormalities, bacteriology and symptoms of sinonasal disease in children with Cystic Fibrosis

Journal of cystic fibrosis, 2016-11, Vol.15 (6), p.816-824

2016

Volltextzugriff (PDF)

Specific airway resistance is a better outcome parameter in bronchial provocation testing compared to FEV 1 in patients with bronchial asthma

The Journal of asthma, 2018-12, Vol.55 (12), p.1338-1342

2018

Volltextzugriff (PDF)

Importance of bacteriology in upper airways of patients with Cystic Fibrosis

Journal of cystic fibrosis, 2013-09, Vol.12 (5), p.525-529

2013

Volltextzugriff (PDF)

Females with cystic fibrosis have a larger decrease in sweat chloride in response to lumacaftor/ivacaftor compared to males

Journal of cystic fibrosis, 2021-01, Vol.20 (1), p.e7-e11

2021

Volltextzugriff (PDF)

Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype deltaF508/S1215N

Journal of cystic fibrosis, 2015-05, Vol.14 (3), p.412-413

2015

Volltextzugriff (PDF)

Long‐term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutation

Pediatric pulmonology, 2020-06, Vol.55 (6), p.1400-1405

2020

Volltextzugriff (PDF)

Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization

Journal of aerosol medicine and pulmonary drug delivery, 2016-06, Vol.29 (3), p.273-280

2016

Volltextzugriff (PDF)

Systemic absorption of nasally administered tobramycin and colistin in patients with cystic fibrosis

Journal of antimicrobial chemotherapy, 2014-11, Vol.69 (11), p.3112-3115

2014

Volltextzugriff (PDF)

The influence of breathing mode on tobramycin serum levels using the I-neb AAD system in adults with cystic fibrosis

Journal of cystic fibrosis, 2015-11, Vol.14 (6), p.748-754

2015

Volltextzugriff (PDF)

Specific airway resistance is a better outcome parameter in bronchial provocation testing compared to FEV1 in patients with bronchial asthma

The Journal of asthma, 2019-01, Vol.55 (12), p.1338-1342

2019

Volltextzugriff (PDF)

Dry powder inhalation of colistin in cystic fibrosis patients: A single dose pilot study

Journal of cystic fibrosis, 2007-07, Vol.6 (4), p.284-292

2007

Volltextzugriff (PDF)

Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis

Therapeutic drug monitoring, 2006-04, Vol.28 (2), p.219-225

2006

Volltextzugriff (PDF)

Dry powder inhalation of colistin sulphomethate in healthy volunteers: A pilot study

International journal of pharmaceutics, 2007-04, Vol.335 (1-2), p.41-45

2007

Volltextzugriff (PDF)

Authors’ response: Letter to the Editor ‘Anaemia and iron deficiency in relation to fatigue in cystic fibrosis

Journal of cystic fibrosis, 2019-01, Vol.18 (1), p.e6-e7

2019

Volltextzugriff (PDF)

Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients

Clinical microbiology and infection, 2011-03, Vol.17 (3), p.382-385

2011

Volltextzugriff (PDF)

Long-term effects of birth order and age at diagnosis in cystic fibrosis: A sibling cohort study

Pediatric pulmonology, 2010-06, Vol.45 (6), p.601-607

2010

Volltextzugriff (PDF)

1 – 25 von 190

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(162)

Publikationsform

Sprache

Englisch
(156)
Niederländisch
(33)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(95)
Science & Technology
(95)
Humans
(86)
Adult
(57)
Female
(56)
Male
(56)
Cystic Fibrosis
(55)
Biological And Medical Sciences
(44)
Medical Sciences
(41)
Respiratory System
(41)
Cystic Fibrosis - Drug Therapy
(34)
Adolescent
(29)
Pharmacology. Drug Treatments
(29)
Cystic Fibrosis - Complications
(26)
Middle Aged
(23)
Pharmacology & Pharmacy
(22)
Anti-Bacterial Agents - Administration & Dosage
(19)
Child
(19)
Pulmonary/respiratory
(18)
Administration, Inhalation
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of azithromycin on sputum inflammatory markers in bronchiectasis

Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype

Sinonasal manifestations of cystic fibrosis: A correlation between genotype and phenotype?

Effectiveness of pulmonary rehabilitation at high-altitude compared to sea-level in adults with severe refractory asthma

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus

Non-fasting bioelectrical impedance analysis in cystic fibrosis: Implications for clinical practice and research

Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥ 90% predicted at baseline

Resting energy expenditure in cystic fibrosis patients decreases after lung transplantation, which improves applicability of prediction equations for energy requirement

The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol

CT-abnormalities, bacteriology and symptoms of sinonasal disease in children with Cystic Fibrosis

Specific airway resistance is a better outcome parameter in bronchial provocation testing compared to FEV 1 in patients with bronchial asthma

Importance of bacteriology in upper airways of patients with Cystic Fibrosis

Females with cystic fibrosis have a larger decrease in sweat chloride in response to lumacaftor/ivacaftor compared to males

Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype deltaF508/S1215N

Long‐term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutation

Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization

Systemic absorption of nasally administered tobramycin and colistin in patients with cystic fibrosis

The influence of breathing mode on tobramycin serum levels using the I-neb AAD system in adults with cystic fibrosis

Specific airway resistance is a better outcome parameter in bronchial provocation testing compared to FEV1 in patients with bronchial asthma

Dry powder inhalation of colistin in cystic fibrosis patients: A single dose pilot study

Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis

Dry powder inhalation of colistin sulphomethate in healthy volunteers: A pilot study

Authors’ response: Letter to the Editor ‘Anaemia and iron deficiency in relation to fatigue in cystic fibrosis

Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients

Long-term effects of birth order and age at diagnosis in cystic fibrosis: A sibling cohort study

Suchergebnisse filtern